Contrasting anti-obesity effects of smectite clays and mesoporous silica in sprague-dawley rats
| Autor: | Tahlia R. Meola, Paul Joyce, Miia Kovalainen, Hanna Ulmefors, Anthony Wignall, Tahnee J. Dening, Clive A. Prestidge |
|---|---|
| Přispěvatelé: | Joyce, Paul, Dening, Tahnee J, Meola, Tahlia R, Wignall, Anthony, Ulmefors, Hanna, Kovalainen, Miia, Prestidge, Clive A |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
obesity anti-obesity Chemistry Biochemistry (medical) Biomedical Engineering 02 engineering and technology General Chemistry Metabolism Mesoporous silica 010402 general chemistry 021001 nanoscience & nanotechnology 01 natural sciences 0104 chemical sciences Biomaterials Endocrinology Anti obesity Internal medicine Sprague dawley rats medicine lipolysis Lipolysis fat digestion 0210 nano-technology functional foods |
| Popis: | Porous colloids have been shown to exert unique bioactivities for mediating lipid (fat) metabolism and thereby offer significant potential as anti-obesity therapies. In this study, we compare the capacity for two classes of colloids, that is, smectite clays (Laponite XLG, LAP; montmorillonite, MMT) and mesoporous silica (SBA-15 ordered silica; MPS), to impede intestinal lipid hydrolysis and provoke lipid and carbohydrate excretion through adsorption within their particle matrices. A two-stage in vitro gastrointestinal lipolysis model revealed the capacity for both smectite clays and MPS to inhibit the rate and extent of lipase-mediated digestion under simulated fed state conditions. Each system adsorbed more than its own weight of organic media (i.e., lipid and carbohydrates) after 60 min lipolysis, with MMT adsorbing >10% of all available organics through the indiscriminate adsorption of fatty acids and glycerides. When co-administered with a high-fat diet (HFD) to Sprague-Dawley rats, treatment with MMT and MPS significantly reduced normalized rodent weight gain compared to a negative control, validating their potential to restrict energy intake and serve as anti-obesity therapies. However, in vitro-in vivo correlations revealed poor associations between in vitro digestion parameters and normalized weight gain, indicating that additional/alternate anti-obesity mechanisms may exist in vivo, while also highlighting the need for improved in vitro assessment methodologies. Despite this, the current findings emphasize the potential for porous colloids to restrict weight gain and promote anti-obesity effects to subjects exposed to a HFD and should therefore drive the development of next-generation food-grade biomaterials for the treatment and prevention of obesity. Refereed/Peer-reviewed |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|